NCT03400384 (TAPERING) is a NA clinical trial of Direct-to-consumer educational brochure in Inappropriate Dose of Drug Administered, sponsored by Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal.

Who is sponsoring NCT03400384?

NCT03400384 is sponsored by Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal.

What drugs are being tested in NCT03400384?

Interventions in NCT03400384: Direct-to-consumer educational brochure.

What condition does NCT03400384 study?

NCT03400384 studies Inappropriate Dose of Drug Administered, Pain, Chronic, Health Behavior.

Is NCT03400384 still recruiting?

NCT03400384 is currently completed. Last updated 29 September 2020.

Last reviewed 2020-09-29 · How we verify

NCT03400384: TAPERING

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Trial Applying Policy to Eliminate or Reduce Inappropriate Narcotics in the General-population

Completed NA Last updated 29 September 2020

What this trial tests

NA trial testing Direct-to-consumer educational brochure in Inappropriate Dose of Drug Administered in 4,255 participants. Completed in 31 December 2019.

Timeline

17 July 2018

Primary endpoint
30 April 2019

31 December 2019

Quick facts

Lead sponsor	Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	health services research
Enrollment	4,255
Start date	17 July 2018
Primary completion	30 April 2019
Estimated completion	31 December 2019
Sites	1 location across Canada

Drugs / interventions tested

Direct-to-consumer educational brochure

Conditions studied

Inappropriate Dose of Drug Administered — all drugs for Inappropriate Dose of Drug Administered →
Pain, Chronic — all drugs for Pain, Chronic →
Health Behavior — all drugs for Health Behavior →

Sponsor

Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal

Who can join

18 and older, any sex, with Inappropriate Dose of Drug Administered or Pain, Chronic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To assess the effectiveness of a government-led population-based opioid intervention on discontinuation of opioid medication in community-dwelling adults with chronic non-cancer pain.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Leveraging policy to reduce chronic opioid use by educating and empowering community dwelling adults: a study protocol for the TAPERING randomized controlled trial.
Turner JP, Caetano P, Tannenbaum C. · · 2019 · cited 5× · PMID 31288859 · DOI 10.1186/s13063-019-3508-z
Government Direct-to-Consumer Education to Reduce Prescription Opioid Use: A Cluster Randomized Clinical Trial.
Turner JP, Halme AS, Caetano P, Langford A, et al · · 2024 · cited 4× · PMID 38809554 · DOI 10.1001/jamanetworkopen.2024.13698

Verify or expand the search:

Other Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal trials

Trials by the same sponsor.

NCT06888713 — Telemonitoring of Activities of Daily Living in Home Care Services of Older Adults with Cognitive Deficits · NA · not yet recruiting
NCT07427693 — Usability, Acceptability and Effect of a Mobile Application and Connected Object for Older Women With UI · NA · active not recruiting
NCT06110234 — Efficacy, Transfer, and Neuro-functional Basis of a Memory Training Targeting Episodic Retrieval in Older Adults. · NA · completed
NCT03506672 — Assessing the Effectiveness of an Approach for Vocal Behaviors in Older People Living in Nursing Homes · NA · completed
NCT03532113 — Attentional Control Training in Older Adults: Efficacy, Transfer and Brain Substrates · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03400384 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal
Last refreshed: 29 September 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03400384.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing